共 11 条
[6]
The catalytically active secretory phospholipase A 2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL[J] . Aleksandra A. Korotaeva,Elena V. Samoilova,Aleksander I. Kaminny,Alejsandra A. Pirkova,Therese J. Resink,Paul Erne,Nina V. Prokazova,Vsevolod A. Tkachuk,Evgeny I. Chazov.Molecular and Cellular Biochemistry . 2005 (1)
[7]
Postprandial Increase in Plasma Concentrations of Remnant-Like Particles: An Independent Risk Factor for Restenosis after Percutaneous Coronary Intervention[J] . Keiji Oi,Hiroaki Shimokawa,Yoji Hirakawa,Hideki Tashiro,Ryuichi Nakaike,Toshiyuki Kozai,Keizaburo Ohzono,Kunihiko Yamamoto,Samon Koyanagi,Shuichi Okamatsu,Tsukasa Tajimi,Yutaka Kikuchi,Akira Takeshita.Journal of Cardiovascular Pharmacology . 2004 (1)
[8]
Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial[J] . The Lancet . 2001 (9274)